Dual defect in metabolism of very-low-density lipoprotein triglycerides. Patients with type 5 hyperlipoproteinemia.
Kesaniemi YA, Grundy SM.
JAMA. 1984 May 18;251(19):2542-7.
The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT.
J Atheroscler Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200.
High-density lipoprotein turnover.
Nestel PJ.
Am Heart J. 1987 Feb;113(2 Pt 2):518-21. doi: 10.1016/0002-8703(87)90624-7.
Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
Dallongeville J, Boulet L, Davignon J, Lussier-Cacan S.
Arterioscler Thromb. 1991 Jul-Aug;11(4):864-71. doi: 10.1161/01.atv.11.4.864.
Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T, Shepherd J, Packard CJ.
Klin Wochenschr. 1988 Aug 15;66(16):703-12. doi: 10.1007/BF01726412.
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
Packard CJ, Shepherd J, Joerns S, Gotto AM Jr, Taunton OD.
Biochim Biophys Acta. 1979 Feb 26;572(2):269-82. doi: 10.1016/0005-2760(79)90042-0.
Familial hypertriglyceridemia/polygenic hypertrigliceridemia.
Lahoz C, Mostaza JM.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:37-42. doi: 10.1016/j.arteri.2020.12.014.
Models and mechanisms in very low density lipoprotein metabolism.
Packard CJ, Shepherd J.
Eur J Clin Invest. 1985 Apr;15(2):51-2. doi: 10.1111/j.1365-2362.1985.tb00143.x.
Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia.
Dunn FL, Grundy SM, Bilheimer DW, Havel RJ, Raskin P.
Metabolism. 1985 Apr;34(4):316-24. doi: 10.1016/0026-0495(85)90220-3.
Very low density lipoprotein metabolism in diabetes mellitus.
Ginsberg HN.
Diabetes Metab Rev. 1987 Apr;3(2):571-89. doi: 10.1002/dmr.5610030209.
